Association of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use With Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Patients With Stabilized Acute Myocardial Infarction: A Propensity Score Matching Study.

Chang, Ting-Yung; Lu, Chi-Ting; Huang, Hsin-Lei; Chou, Ruey-Hsing; Chang, Chun-Chin; Liu, Chung-Te; Huang, Po-Hsun; Lin, Shing-Jong

Chang, Ting-Yung; Lu, Chi-Ting; Huang, Hsin-Lei; Chou, Ruey-Hsing; Chang, Chun-Chin; Liu, Chung-Te; Huang, Po-Hsun; Lin, Shing-Jong.

Afiliação

Chang TY; Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Lu CT; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Huang HL; Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
Chou RH; Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chang CC; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Liu CT; Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Huang PH; Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
Lin SJ; Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Front Cardiovasc Med ; 9: 882181, 2022.

Article em En | MEDLINE | ID: mdl-35571176

Palavras-chave

SGLT2 inhibitor; diabetes; hospitalization; mortality; myocardial infarction

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google